Hybrid And Tandem Expression Of Neisserial Proteins

Patent No. EP2327719 (titled "Hybrid And Tandem Expression Of Neisserial Proteins") was filed by GlaxoSmithKline Biologicals SA on Sep 6, 2002. The application was issued on Aug 20, 2014.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
PFIZERMay 20, 2015PFIZER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2327719

GLAXOSMITHKLINE BIOLOGICALS SA
Application Number
EP10179755A
Filing Date
Sep 6, 2002
Status
Revoked
Apr 15, 2019
Publication Date
Aug 20, 2014